Researchers Say HCC Risk After Five Years Of Antiviral Therapy Depends On Several Factors In White Patients With Chronic Hepatitis B

Infectious Disease Advisor (3/20, Schad) reported researchers found in “a large multicenter ongoing cohort study” that “in white patients with chronic hepatitis B, the risk for hepatocellular carcinoma (HCC) after the first 5 years of receiving antiviral...